SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $272,000 | -51.7% | 13,036 | -45.0% | 0.00% | -50.0% |
| Q2 2020 | $563,000 | +31.9% | 23,694 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $427,000 | -31.8% | 23,694 | -10.2% | 0.01% | +16.7% |
| Q4 2019 | $626,000 | -13.8% | 26,394 | 0.0% | 0.01% | -25.0% |
| Q3 2019 | $726,000 | -16.9% | 26,394 | 0.0% | 0.01% | -11.1% |
| Q2 2019 | $874,000 | -5.5% | 26,394 | 0.0% | 0.01% | -10.0% |
| Q1 2019 | $925,000 | +5.5% | 26,394 | 0.0% | 0.01% | -9.1% |
| Q4 2018 | $877,000 | -34.0% | 26,394 | 0.0% | 0.01% | -15.4% |
| Q3 2018 | $1,329,000 | -15.9% | 26,394 | 0.0% | 0.01% | -18.8% |
| Q2 2018 | $1,580,000 | +48.1% | 26,394 | +13.3% | 0.02% | +45.5% |
| Q1 2018 | $1,067,000 | +15.0% | 23,287 | +0.0% | 0.01% | +22.2% |
| Q4 2017 | $928,000 | 0.0% | 23,277 | +0.3% | 0.01% | +12.5% |
| Q3 2017 | $928,000 | -7.2% | 23,204 | 0.0% | 0.01% | -11.1% |
| Q2 2017 | $1,000,000 | +240.1% | 23,204 | +20.2% | 0.01% | +200.0% |
| Q1 2016 | $294,000 | +20.0% | 19,300 | +6.0% | 0.00% | +50.0% |
| Q4 2015 | $245,000 | – | 18,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |